{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:59:39Z","timestamp":1793224779307,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s10067-020-04973-0","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T01:03:16Z","timestamp":1588899796000},"page":"3489-3497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodies"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5305-7770","authenticated-orcid":false,"given":"Yasuhito","family":"Hamaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Kuwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,8]]},"reference":[{"issue":"4","key":"4973_CR1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0889-857X(02)00032-7","volume":"28","author":"IN Targoff","year":"2002","unstructured":"Targoff IN (2002) Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies. Rheumatic diseases clinics of North America 28(4):859\u2013890","journal-title":"Rheumatic diseases clinics of North America"},{"issue":"5","key":"4973_CR2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","volume":"14","author":"NJ McHugh","year":"2018","unstructured":"McHugh NJ, Tansley SL (2018) Autoantibodies in myositis. Nat Rev Rheumatol 14(5):290\u2013302","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"4973_CR3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","volume":"35","author":"VD Steen","year":"2005","unstructured":"Steen VD (2005) Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 35(1):35\u201342","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"4973_CR4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1346-8138.2009.00762.x","volume":"37","author":"Y Hamaguchi","year":"2010","unstructured":"Hamaguchi Y (2010) Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. J Dermatol 37(1):42\u201353","journal-title":"J Dermatol"},{"issue":"3","key":"4973_CR5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/2397198318783930","volume":"3","author":"Y Hamaguchi","year":"2018","unstructured":"Hamaguchi Y, Takehara K (2018) Anti-nuclear autoantibodies in systemic sclerosis: news and perspectives. J Scleroderma Relat Dis 3(3):201\u2013213","journal-title":"J Scleroderma Relat Dis"},{"issue":"6","key":"4973_CR6","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/BOR.0000000000000329","volume":"28","author":"M Fujimoto","year":"2016","unstructured":"Fujimoto M, Watanabe R, Ishitsuka Y, Okiyama N (2016) Recent advances in dermatomyositis-specific autoantibodies. Curr Opin Rheumatol 28(6):636\u2013644","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"4973_CR7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/ar628","volume":"5","author":"KT Ho","year":"2003","unstructured":"Ho KT, Reveille JD (2003) The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 5(2):80\u201393","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"4973_CR8","doi-asserted-by":"crossref","first-page":"909","DOI":"10.6061\/clinics\/2013(07)04","volume":"68","author":"MG Cruellas","year":"2013","unstructured":"Cruellas MG, Viana Vdos S, Levy-Neto M, Souza FH, Shinjo SK (2013) Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis. Clinics (Sao Paulo) 68(7):909\u2013914","journal-title":"Clinics (Sao Paulo)"},{"issue":"3","key":"4973_CR9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3349\/ymj.2015.56.3.676","volume":"56","author":"JS Song","year":"2015","unstructured":"Song JS, Hwang J, Cha HS, Jeong BH, Suh GY, Chung MP, Kang ES (2015) Significance of myositis autoantibody in patients with idiopathic interstitial lung disease. Yonsei Med J 56(3):676\u2013683","journal-title":"Yonsei Med J"},{"issue":"12","key":"4973_CR10","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1002\/art.39316","volume":"67","author":"KA Patterson","year":"2015","unstructured":"Patterson KA, Roberts-Thomson PJ, Lester S, Tan JA, Hakendorf P, Rischmueller M, Zochling J, Sahhar J, Nash P, Roddy J, Hill C, Nikpour M, Stevens W, Proudman SM, Walker JG (2015) Interpretation of an extended autoantibody profile in a well-characterized australian systemic sclerosis (Scleroderma) cohort using principal components analysis. Arthritis Rheumatol 67(12):3234\u20133244","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"4973_CR11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/1756-185X.12322","volume":"18","author":"I Sujau","year":"2015","unstructured":"Sujau I, Ng CT, Sthaneshwar P, Sockalingam S, Cheah TE, Yahya F, Jasmin R (2015) Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort. Int J Rheum Dis 18(4):459\u2013465","journal-title":"Int J Rheum Dis"},{"key":"4973_CR12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.rmed.2016.12.014","volume":"123","author":"M Mejia","year":"2017","unstructured":"Mejia M, Herrera-Bringas D, Perez-Roman DI, Rivero H, Mateos-Toledo H, Castorena-Garc\u00eda P, Figueroa JE, Rojas-Serrano J (2017) Interstitial lung disease and myositis-specific and associated autoantibodies: Clinical manifestations, survival and the performance of the new ATS\/ERS criteria for interstitial pneumonia with autoimmune features (IPAF). Respir Med 123:79\u201386","journal-title":"Respir Med"},{"issue":"1","key":"4973_CR13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13075-017-1469-8","volume":"19","author":"H Yang","year":"2017","unstructured":"Yang H, Peng Q, Yin L, Li S, Shi J, Zhang Y, Lu X, Shu X, Zhang S, Wang G (2017) Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study. Arthritis Res Ther 19(1):259\u2013267","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"4973_CR14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/rheumatology\/kex516","volume":"57","author":"J Aouizerate","year":"2018","unstructured":"Aouizerate J, De Antonio M, Bader-Meunier B, Barnerias C, Bodemer C, Isapof A, Quartier P, Melki I, Charuel JL, Bassez G, Desguerre I, Gherardi RK, Authier FJ, Gitiaux C (2018) Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositis. Rheumatology (Oxford). 57(5):873\u2013879","journal-title":"Rheumatology (Oxford)."},{"issue":"1","key":"4973_CR15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.amjms.2017.07.013","volume":"355","author":"F Chen","year":"2018","unstructured":"Chen F, Li S, Wang T, Shi J, Wang G (2018) Clinical heterogeneity of interstitial lung disease in polymyositis and dermatomyositis patients with or without specific autoantibodies. Am J Med Sci. 355(1):48\u201353","journal-title":"Am J Med Sci."},{"issue":"8","key":"4973_CR16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292(8):403\u2013407","journal-title":"N Engl J Med"},{"key":"4973_CR17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"Anonymous","year":"1980","unstructured":"Anonymous (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23:581\u2013590","journal-title":"Arthritis Rheum"},{"key":"4973_CR18","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271\u20131277","journal-title":"Arthritis Rheum"},{"issue":"3","key":"4973_CR19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315\u2013324","journal-title":"Arthritis Rheum"},{"key":"4973_CR20","doi-asserted-by":"crossref","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sj\u00f6gren's Syndrome (2002) Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6): 554-558","DOI":"10.1136\/ard.61.6.554"},{"issue":"3","key":"4973_CR21","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1073\/pnas.77.3.1627","volume":"77","author":"Y Moroi","year":"1980","unstructured":"Moroi Y, Peebles C, Fritzler MJ, Steigerwald J, Tan EM (1980) Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci U S A. 77(3):1627\u20131631","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"4","key":"4973_CR22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archdermatol.2011.52","volume":"147","author":"Y Hamaguchi","year":"2011","unstructured":"Hamaguchi Y, Kuwana M, Hoshino K, Hasegawa M, Kaji K, Matsushita T, Komura K, Nakamura M, Kodera M, Suga N, Higashi A, Ogusu K, Tsutsui K, Furusaki A, Tanabe H, Sasaoka S, Muro Y, Yoshikawa M, Ishiguro N, Ayano M, Muroi E, Fujikawa K, Umeda Y, Kawase M, Mabuchi E, Asano Y, Sodemoto K, Seishima M, Yamada H, Sato S, Takehara K, Fujimoto M (2011) Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol 147(4):391\u2013398","journal-title":"Arch Dermatol"},{"issue":"1","key":"4973_CR23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/annrheumdis-2012-201736","volume":"72","author":"M Fujimoto","year":"2013","unstructured":"Fujimoto M, Matsushita T, Hamaguchi Y, Asano Y, Ogawa F, Yamaoka T, Fujikawa K, Tsukada T, Sato K, Echigo T, Hasegawa M, Takehara K (2013) Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort. Ann Rheum Dis 72(1):151\u2013153","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4973_CR24","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2133.2007.08392.x","volume":"158","author":"Y Hamaguchi","year":"2018","unstructured":"Hamaguchi Y, Hasegawa M, Fujimoto M, Matsushita T, Komura K, Kaji K, Kondo M, Nishijima C, Hayakawa I, Ogawa F, Kuwana M, Takehara K, Sato S (2018) The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis. Br J Dermatol 158(3):487\u2013495","journal-title":"Br J Dermatol"},{"issue":"10","key":"4973_CR25","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/rheumatology\/ken325","volume":"47","author":"S Suzuki","year":"2008","unstructured":"Suzuki S, Satoh T, Sato S, Otomo M, Hirayama Y, Sato H, Kawai M, Ishihara T, Suzuki N, Kuwana M (2008) Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies. Rheumatology (Oxford) 47(10):1539\u20131542","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"4973_CR26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060442","volume":"8","author":"Y Hamaguchi","year":"2013","unstructured":"Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M, Kodera M, Muroi E, Fujikawa K, Seishima M, Yamada H, Yamada R, Sato S, Takehara K, Kuwana M (2013) Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS One 8(4):e60442","journal-title":"PLoS One"},{"issue":"12","key":"4973_CR27","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/rheumatology\/kep290","volume":"48","author":"T Satoh","year":"2009","unstructured":"Satoh T, Ishikawa O, Ihn H, Endo H, Kawaguchi Y, Sasaki T, Goto D, Takahashi K, Takahashi H, Misaki Y, Mimori T, Muro Y, Yazawa N, Sato S, Takehara K, Kuwana M (2009) Rheumatology (Oxford) 48(12):1570\u20131574","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"4973_CR28","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archneurol.2011.1728","volume":"69","author":"S Suzuki","year":"2012","unstructured":"Suzuki S, Hayashi YK, Kuwana M, Tsuburaya R, Suzuki N, Nishino I (2012) Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome. Arch Neurol 69(6):728\u2013732","journal-title":"Arch Neurol"},{"issue":"4","key":"4973_CR29","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/art.38994","volume":"67","author":"Y Hamaguchi","year":"2015","unstructured":"Hamaguchi Y, Kodera M, Matsushita T et al (2015) Clinical and immunologic predictors of scleroderma renal crisis in japanese systemic sclerosis patients with anti-rna polymerase III autoantibodies. Arthritis Rheumatol 67(4):1045\u20131052","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"4973_CR30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3899\/jrheum.160618","volume":"44","author":"R Aggarwal","year":"2017","unstructured":"Aggarwal R, Dhillon N, Fertig N, Koontz D, Qi Z, Oddis CV (2017) A negative antinuclear antibody does not indicate autoantibody negativity in myositis: role of anticytoplasmic antibody as a screening test for antisynthetase syndrome. J Rheumatol 44(2):223\u2013229","journal-title":"J Rheumatol"},{"key":"4973_CR31","doi-asserted-by":"crossref","unstructured":"Homer KL, Warren J, Karayev D, Khanna PP, Young A, Nagaraja V, Metzger AL, Khanna D (2018) Performance of anti-topoisomerase i antibody testing by multiple-bead, enzyme-linked immunosorbent assay and immunodiffusion in a university setting. J Clin Rheumatol","DOI":"10.1097\/RHU.0000000000000971"},{"key":"4973_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2016.02.017","volume":"433","author":"I Cavazzana","year":"2016","unstructured":"Cavazzana I, Fredi M, Ceribelli A, Mordenti C, Ferrari F, Carabellese N, Tincani A, Satoh M, Franceschini F (2016) Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera. J Immunol Methods 433:1\u20135","journal-title":"J Immunol Methods"},{"issue":"2","key":"4973_CR33","first-page":"56","volume":"84","author":"M Kuwana","year":"2017","unstructured":"Kuwana M (2017) Circulating Anti-Nuclear Antibodies in Systemic Sclerosis: Utility in Diagnosis and Disease Subsetting J Nippon Med Sch 84(2):56\u201363","journal-title":"Circulating Anti-Nuclear Antibodies in Systemic Sclerosis: Utility in Diagnosis and Disease Subsetting J Nippon Med Sch"},{"issue":"3","key":"4973_CR34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/14397595.2016.1213947","volume":"27","author":"Y Hamaguchi","year":"2017","unstructured":"Hamaguchi Y, Kuwana M, Takehara K (2017) Comparison of anti-OJ antibody detection assays between an immunoprecipitation assay and line blot assay. Mod Rheumatol. 27(3):551\u2013552","journal-title":"Mod Rheumatol."},{"issue":"7","key":"4973_CR35","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.autrev.2019.05.002","volume":"18","author":"JB Vulsteke","year":"2019","unstructured":"Vulsteke JB, Satoh M, Malyavantham K, Bossuyt X, De Langhe E, Mahler M (2019) Anti-OJ autoantibodies: Rare or underdetected? Autoimmun Rev 18(7):658\u2013664","journal-title":"Autoimmun Rev"},{"issue":"6","key":"4973_CR36","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/annrheumdis-2018-214690","volume":"78","author":"F Espinosa-Ortega","year":"2019","unstructured":"Espinosa-Ortega F, Holmqvist M, Alexanderson H, Storfors H, Mimori T, Lundberg IE, R\u00f6nnelid J (2019) Comparison of autoantibody specificities tested by a line blot assay and immunoprecipitation-based algorithm in patients with idiopathic inflammatory myopathies. Ann Rheum Dis 78(6):858\u2013860","journal-title":"Ann Rheum Dis"},{"key":"4973_CR37","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3389\/fimmu.2019.00848","volume":"10","author":"M Mahler","year":"2019","unstructured":"Mahler M, Betteridge Z, Bentow C, Richards M, Seaman A, Chinoy H, McHugh N (2019) Comparison of three immunoassays for the detection of myositis specific antibodies. Front Immunol 10:848","journal-title":"Front Immunol"},{"issue":"1","key":"4973_CR38","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-212915","volume":"78","author":"JB Vulsteke","year":"2019","unstructured":"Vulsteke JB, De Langhe E, Claeys KG, Dillaerts D, Poesen K, Lenaerts J, Westhovens R, Van Damme P, Blockmans D, De Haes P, Bossuyt X (2019) Detection of myositis-specific antibodies. Ann Rheum Dis 78(1):e7","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"4973_CR39","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1007\/s00415-019-09266-4","volume":"266","author":"F Montagnese","year":"2019","unstructured":"Montagnese F, Babacic H, Eichhorn P, Schoser B (2019) Evaluating the diagnostic utility of new line immunoassays for myositis antibodies in clinical practice: a retrospective study. J Neurol 266(6):1358\u20131366","journal-title":"J Neurol"},{"issue":"1","key":"4973_CR40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10067-018-4267-z","volume":"38","author":"E Zampeli","year":"2019","unstructured":"Zampeli E, Venetsanopoulou A, Argyropoulou OD, Mavragani CP, Tektonidou MG, Vlachoyiannopoulos PG, Tzioufas AG, Skopouli FN, Moutsopoulos HM (2019) Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies. Clin Rheumatol 38(1):125\u2013132","journal-title":"Clin Rheumatol"},{"issue":"4","key":"4973_CR41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pathol.2016.03.012","volume":"48","author":"C Bundell","year":"2016","unstructured":"Bundell C, Rojana-Udomsart A, Mastaglia F, Hollingsworth P, McLean-Tooke A (2016) Diagnostic performance of a commercial immunoblot assay for myositis antibody testing. Pathology 48(4):363\u2013366","journal-title":"Pathology"},{"issue":"11","key":"4973_CR42","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s10067-015-2981-3","volume":"34","author":"WS Chang","year":"2015","unstructured":"Chang WS, Schollum J, White DH, Solanki KK (2015) A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New Zealand. Clin Rheumatol 34(11):1921\u20131927","journal-title":"Clin Rheumatol"},{"issue":"10","key":"4973_CR43","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1111\/1756-185X.13060","volume":"20","author":"C Foocharoen","year":"2017","unstructured":"Foocharoen C, Watcharenwong P, Netwijitpan S, Mahakkanukrauh A, Suwannaroj S, Nanagara R (2017) Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais. Int J Rheum Dis 20(10):1572\u20131581","journal-title":"Int J Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-04973-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-04973-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-04973-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T20:28:12Z","timestamp":1620419292000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-04973-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,8]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["4973"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-04973-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,8]]},"assertion":[{"value":"10 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial support"}},{"value":"All study participants provided written informed consent. The protocol was approved by Kanazawa University and Keio University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"M.K. received patent fees from MBL, INOVA, and Phadia. Other authors have no conflict of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}